InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,604.37
(
0.41%
)
US TECH 100
15,653.20
(
-0.21%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.58
(
-0.54%
)
Bitcoin
42,343.72
(
-3.29%
)
Post# of 250026
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 58
Posts 11315
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: None

Monday, 10/05/2020 6:23:54 AM

Monday, October 05, 2020 6:23:54 AM

Post# of 250026
Bristol-Myers to buy MyoKardia for $13.1B, or $225/share in cash, WSJ reports

Bristol-Myers (BMY) will buy MyoKardia (MYOK) for $225 a share in cash, or $13.1B, The Wall Street Journal's Jared S. Hopkins reports.

MyoKardia's lead pipeline drug, code-named mavacamten, treats a chronic heart condition that can cause irregular heart rhythms in some patients and even death. Bristol plans to ask U.S. health regulators next year to approve the drug, Bristol CEO Giovanni Caforio says.

Read more at:
https://thefly.com/n.php?id=3169816
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up